12-Month Lobbying Summary - In-house Corporation

Merck Canada Inc. - Address & business activities

Address:

16750 TransCanada Highway
Kirkland, QC  H9H 4M7
Canada

Telephone number: 514-428-2638

• Contact information in previous versions

  • 16750 TransCanada Highway
    Kirkland, QC  H9H 4M7
    Canada
    
    Telephone number: 514-428-2638
    
    Fax number: 514-428-2662  
    
    
  • 16750 TransCanada Highway
    Kirkland, QC  H9H 4M7
    Canada
    
    Telephone number: 514-428-7920
    
    Fax number: 514-428-4955  
    
    
  • 16750 TransCanada Highway
    Kirkland, QC  H9H 4M7
    Canada
    
    Telephone number: 514-428-7920
    
    Fax number: 514-428-4955  
    
    
  • 16711 TransCanada Highway
    Kirkland, QC  H9H 3L1
    Canada
    
    Telephone number: 514-428-7920
    
    Fax number: 514-428-4955  
    
    
  • 16711 TransCanada Highway
    Kirkland, QC  H9H 3L1
    Canada
    
    Telephone number: 514-428-2638
    
    Fax number: 514-428-2662  
    
    
  • 16711 TransCanada Highway
    Kirkland, QC  H9H 3L1
    Canada
    
    Telephone number: 514-428-7920
    
    
  • 16711 TransCanada Highway
    Kirkland, QC  H9H 3L1
    Canada
    
    Telephone number: 514-426-7300
    
    
  • 16711 TransCanada Highway
    Kirkland, QC  H9H 3L1
    Canada
    
    Telephone number: 514-428-2609
    
    
  • 16711 TransCanada Highway
    Kirkland, QC  H9H 3L1
    Canada
    
    Telephone number: 514-428-3788
    
    Fax number: 514-428-3892  
    
    
  • 16711 TRANSCANADA HIGHWAY
    KIRKLAND, QC  H9H 3L1
    Canada
    
    Telephone number: 514-428-3788
    
    Fax number: 514-428-3892  
    
    

Description of activities:
For over a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola. For more information about our operations in Canada, visit www.merck.ca and connect with us on YouTube and Twitter @MerckCanada.

• Descriptions of the corporation's activity in previous versions:

  • For 125 years, Merck has been working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines and animal health products. In Canada, Merck markets more than 250 pharmaceutical and animal health products. Merck is a leader in a broad range of areas such as cardiology, infectious diseases, respiratory, vaccines and women's health, and is focused on expanding offerings in other areas, including virology, oncology and diabetes. Based in Montréal, Québec, Merck employs approximately 795 people across Canada. Merck is one of the top R&D investors in Canada, with investments totalling $29.9 million in 2014 and more than $1 billion since 2000. For more information about our operations in Canada, visit www.merck.ca and connect with us on YouTube.
  • Today’s Merck is working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines and animal health products. In Canada, Merck markets more than 250 pharmaceutical and animal health products. Merck is a leader in a broad range of areas such as cardiology, infectious diseases, respiratory, vaccines and women's health, and is focused on expanding offerings in other areas, including virology, oncology and diabetes. Based in Montréal, Québec, Merck employs approximately 975 people across Canada. The Merck Canada manufacturing facility in Québec has been designated by its parent company as a Centre of Excellence for the global production of liquids, ointments and creams. Merck is one of the top R&D investors in Canada, with investments totalling $22.6 million in 2013 and more than $1 billion since 2000. For more information about our operations in Canada, visit www.merck.ca.
  • Today’s Merck is working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines, consumer care and animal health products. In Canada, Merck markets more than 530 pharmaceutical, consumer care and animal health products. Merck is a leader in a broad range of areas such as cardiology, infectious diseases, respiratory, vaccines, women's health and sun care, and is focused on expanding offerings in other areas, including virology, oncology and diabetes. Based in Montréal, Québec, Merck employs approximately 1150 people across Canada. The Merck Canada manufacturing facility in Québec has been designated by its parent company as a Centre of Excellence for the global production of liquids, ointments and creams. Merck is one of the top R&D investors in Canada, with investments totalling $39.7 million in 2012 and more than $1 billion since 2000. For more information about our operations in Canada, visit www.merck.ca.
  • Today’s Merck is working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines, consumer and animal health products. In Canada, Merck markets more than 530 pharmaceutical, consumer and animal health products. Merck is a leader in a broad range of areas such as cardiology, infectious diseases, respiratory, vaccines, women's health and sun care, and is focused on expanding offerings in other areas, including virology, oncology and diabetes. Based in Montréal, Québec, Merck employs approximately 1250 people across Canada. The Merck Canada manufacturing facility in Québec has been designated by its parent company as a Centre of Excellence for the global production of liquids, ointments and creams. Merck is one of the top R&D investors in Canada, with investments totalling $26.1 million in 2011. For more information about our operations in Canada, visit www.merck.ca.
  • Today’s Merck is working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines, consumer and animal health products. In Canada, Merck markets more than 530 pharmaceutical, consumer and animal health products. Merck is a leader in a broad range of areas such as cardiology, infectious diseases, respiratory, vaccines, women's health and sun care, and is focused on expanding offerings in other areas, including virology, oncology and diabetes. Based in Montréal, Québec, Merck employs approximately 1250 people across Canada. The Merck Canada manufacturing facility in Québec has been designated by its parent company as a Centre of Excellence for the global production of liquids, ointments and creams. Merck is one of the top R&D investors in Canada, with investments totalling $78.6 million in 2010. For more information about our operations in Canada, visit www.merck.ca.
  • Today’s Merck is working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines, consumer and animal health products. In Canada, Merck markets more than 530 pharmaceutical, consumer and animal health products. Merck is a leader in a broad range of areas such as cardiology, infectious diseases, respiratory, vaccines, women's health and sun care, and is focused on expanding offerings in other areas, including virology, oncology and diabetes. Based in Montréal, Québec, Merck employs more than 1250 people across Canada. The Merck Canada manufacturing facility in Québec has been designated by its parent company as a Centre of Excellence for the global production of liquids, ointments and creams. Merck is one of the top R&D investors in Canada, with investments totalling $78.6 million in 2010. For more information about our operations in Canada, visit www.merck.ca.
  • Today’s Merck is working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines, consumer and animal health products. In Canada, Merck markets more than 530 pharmaceutical, consumer and animal health products. Merck is a leader in a broad range of areas such as cardiology, infectious diseases, respiratory, vaccines, women's health and sun care, and is focused on expanding offerings in other areas, including virology, oncology and diabetes. Based in Montréal, Québec, Merck employs more than 1400 people across Canada. The Merck Canada manufacturing facility in Québec has been designated by its parent company as a Centre of Excellence for the global production of liquids, ointments and creams. Merck is one of the top R&D investors in Canada, with investments totalling $78.6 million in 2010. For more information about our operations in Canada, visit www.merck.ca.
  • Today’s Merck is working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines, consumer and animal health products. In Canada, Merck markets over 530 pharmaceutical, consumer and animal health products. Merck is a leader in a broad range of areas such as cardiology, infectious diseases, respiratory, vaccines, women's health and sun care, and is focused on expanding offerings in other areas, including virology, oncology and diabetes. Merck is one of the top R&D investors in Canada, with an investment of $78.6 million in 2010. Merck has a large manufacturing facility in Québec dedicated to the annual production of some 35 million units of its various brands, including Claritin® and Aerius®. Based in Montréal, Québec, Merck employs over 1400 people across Canada. For more information about our operations in Canada, visit www.merck.ca.
  • Today’s Merck is working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines, consumer and animal health products. In Canada, Merck markets over 530 pharmaceutical, consumer and animal health products. Merck is a leader in a broad range of areas such as cardiology, infectious diseases, respiratory, vaccines, women's health and sun care, and is focused on expanding offerings in other areas, including virology, oncology and diabetes. Merck is one of the top 25 R&D investors in Canada, with an investment of $95.4 million in 2009. Merck has a large manufacturing facility in Québec dedicated to the annual production of some 35 million units of its various brands, including Claritin® and Aerius®. Based in Montréal, Québec, Merck employs over 1600 people across Canada. For more information about our operations in Canada, visit www.merck.ca.
  • Today’s Merck is working to help the world be well. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines, consumer and animal health products. In Canada, Merck markets over 530 pharmaceutical, consumer and animal health products and is a leader in a broad range of areas such as cardiology, immunology, infectious diseases, respiratory, vaccines, women's health and sun care, and is focused on expanding offerings in other areas, including virology, oncology and diabetes. Merck is one of the top 25 R&D investors in Canada, with an investment of $95.4 million in 2009. Merck also has a large manufacturing facility in Quebec dedicated to the annual production of some 35 million units including the Claritin and Aerius brands. Based in Montréal, Quebec, Merck employs over 1600 people across Canada. For more information about our operations in Canada, visit www.merck.ca. *Merck Frosst Canada Ltd. and Schering-Plough Canada Inc. are integrating their operations to form a new organization called Merck.
  • *Merck Frosst Canada Ltd. and Schering-Plough Canada Inc. are integrating their operations to form a new organization called Merck. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines, consumer and animal health products. In Canada, Merck markets over 530 pharmaceutical, consumer and animal health products and is a leader in a broad range of areas such as cardiology, immunology, infectious diseases, respiratory, vaccines, women's health and sun care, and is focused on expanding offerings in other areas, including virology, oncology and diabetes. Merck is one of the top R&D investors in Canada, with an investment of $95 million in 2009. Merck also has a large manufacturing facility in Quebec dedicated to the annual production of some 35 million units including the Claritin and Aerius brands. Based in Montréal, Quebec, Merck employs over 1600 people across Canada. For more information about our operations in Canada visit www.merckfrosst.com or www.schering-plough.ca.
  • *Merck Frosst Canada Ltd. and Schering-Plough Canada Inc. are integrating their operations to form a new organization called Merck. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines, consumer and animal health products. In Canada, Merck markets over 530 pharmaceutical, consumer and animal health products and is a leader in a broad range of areas such as cardiology, immunology, infectious diseases, respiratory, vaccines, women's health and sun care, and is focused on expanding offerings in other areas, including virology, oncology and diabetes. Merck is one of the top 25 R&D investors in Canada, with an investment of $121 million in 2008 and has one of the largest biomedical research facilities in Canada with the mandate to discover new therapies for the treatment of infectious diseases. Merck also has a large manufacturing facility in Quebec dedicated to the annual production of some 35 million units including the Claritin and Aerius brands. Based in Montréal, Quebec, Merck employs over 1800 people across Canada. For more information about our operations in Canada visit www.merckfrosst.com or www.schering-plough.ca.
  • At Merck Frosst, patients come first. Merck Frosst Canada Ltd. is a research-driven pharmaceutical company. Merck Frosst discovers, develops and markets a broad range of innovative medicines to improve human health. The Merck Frosst Centre for Therapeutic Research, one of the largest biomedical research facilities in Canada, has the mandate to discover new therapies for the treatment of respiratory diseases, inflammatory diseases, diabetes, osteoporosis and hypertension. Merck Frosst is one of the top 20 R&D investors in Canada, with an investment of $114 million in 2006. The Company is committed to fostering partnerships to deliver the most valuable health outcomes for Canadian patients. Merck Frosst is a recognized leader in the treatment of asthma, osteoporosis, HIV/AIDS, glaucoma, prostate disease, migraines and infectious diseases. The Company also markets an extensive line of cardiovascular products for high blood pressure, elevated cholesterol and heart failure as well as a broad range of vaccines. Based in Montréal, Quebec, Merck Frosst employs nearly 1,600 people including more than 300 of the world's leading scientific personnel. It is also firmly committed to science education and sponsors a number of programs designed to spark young people's interest in science. More information about Merck Frosst is available at http://www.merckfrosst.com
  • At Merck Frosst, patients come first. Merck Frosst Canada Ltd. is a research-driven pharmaceutical company. Merck Frosst discovers, develops and markets a broad range of innovative medicines to improve human health. The Merck Frosst Centre for Therapeutic Research, one of the largest biomedical research facilities in Canada, has the mandate to discover new therapies for the treatment of respiratory diseases, inflammatory diseases, diabetes and osteoporosis. Merck Frosst is one of the top 20 R&D investors in Canada, with an investment of $117 million in 2004. The Company is committed to fostering partnerships to deliver the most valuable health outcomes for Canadian patients. Merck Frosst is a recognized leader in the treatment of asthma, osteoporosis, HIV/AIDS, glaucoma, prostate disease, migraines and infectious diseases. The Company also markets an extensive line of cardiovascular products for high blood pressure, elevated cholesterol and heart failure as well as a broad range of vaccines. Based in Montréal, Quebec, Merck Frosst employs nearly 1,600 people including more than 300 of the world's leading scientific personnel. It is also firmly committed to science education and sponsors a number of programs designed to spark young people's interest in science. More information about Merck Frosst is available at http://www.merckfrosst.com
  • MFCC IS ONE OF CANADA'S LARGEST RESEARCH-BASED PHARMACEUTICAL COMPANY WITH ROOTS GOING BACK TO 1899. THE COMPANY IS BASED IN KIRKLAND, QUEBEC WITH OFFICES IN HALIFAX, QUEBEC CITY, OTTAWA, WINNIPEG, CALGARY, EDMONTON AND VANCOUVER. OVER 1,700 PEOPLE ARE EMPLOYED IN THE DISCOVERY, MANUFACTURE AND MARKETING OF PRESCRIPTION MEDICINES. OUR CENTRE FOR THERAPEUTIC RESEARCH ALONE EMPLOYEES OVER 300 SCIENTISTS AND IS THE LARGES BIOMEDICAL RESEARCH CENTRE IN CANADA.

MERCK FROSST COMPANY

1959 Upper Water Street
Suite 900
Halifax, NS  B3J 2X2
Canada

No government funding was received during the last completed financial year.